Advertisement

Picture biomindz Mainz Biomed LSG Colorectal Cancer Screening 650x100px
Document › Details

Insempra GmbH. (11/10/23). "Press Release: Insempra Wins €1.5M Disruptive Innovation Grant with Circular Biomanufacturing Concept »BioTreasure«". Munich.

Region Region Germany
Organisations Organisation Insempra GmbH
  Organisation 2 Sprind GmbH (Bundesagentur für Sprunginnovationen)
  Group Germany (govt)
Products Product BioTreasure bioproduction process using caronaceous waste streams as input
  Product 2 business development (state/region)
Index term Index term Insempra–Germany (govt): grant, 202311–202610 innvoation grant €1.5m from SPRIND to advance BioTreasure prototype
Person Person Klein, Jens (Insempra/Origin.Bio 2022H1 CEO before AMSilk GmbH –201607–202012 CEO LEFT 1/21)
     


Insempra, a biology-powered company enabling businesses to make superior products with nature, has been elected for €1.5 million in funding from The Federal Agency for Disruptive Innovation, SPRIND, in their 2023 circular biomanufacturing challenge for its innovative biomanufacturing prototype, ‘BioTreasure’.

The Federal Agency for Disruptive Innovation, SPRIND supports new innovations and technologies by setting various challenges every year, enabling research institutions, universities, and businesses to compete for funding and expert support in accomplishing key social, ecological, and economic challenges of our time.

Insempra set forth its innovative prototype “BioTreasure” for the SPRIND circular biomanufacturing challenge, which was set to develop an end-to-end prototype that processes various carbonaceous waste streams into new products as a continuous bioproduction process. The prototype is required to demonstrate how carbonaceous waste streams can be processed and fed to microbes as feedstock. Additionally, it must demonstrate continuous production over a period of at least 180 days, resulting in different products being produced using a modern manufacturing process, such as additive manufacturing.

Insempra is proud that the funding also recognizes its pioneering role in circular biomanufacturing practices and at the same time enables the company to expand these activities further. The prototype will help to reduce industry dependencies on resource-intensive materials whilst mitigating waste by utilizing PET/plastic waste, cooking oil waste and second-generation plant waste as resources for its circular biomanufacturing prototype.

By combining industry changing breakthrough technologies such as waste upcycling, continuous fermentation and innovative reactor design, Insempra has developed a circular biomanufacturing prototype that will enable the development of different ingredients/products that can be used as bio-based alternatives for high-tech applications. Thus, Insempra supports the achievement of ESG goals as the current solutions are petroleum derived and Insempra’s technology enables these high-tech applications via means of sustainable circular biomanufactured ingredients.

“As a biology-powered business, establishing circular manufacturing processes has always been one of our highest priorities. Our prototype ‘BioTreasure’, has the potential to revolutionize industries by providing sustainable, vegan and bio-based alternatives for certain materials, maximizing resource efficiency, environmental stewardship and reducing reliance on fossil fuel or other resources extracted from nature. We are excited to embark on this challenge with SPRIND’s support and are incredibly proud of our team.” says Jens Klein, CEO & Founder of Insempra.

The SPRIND challenge will commence from November 2023 for a total of three years. Key objectives of the challenge are to support feedstock diversity and demonstrate the economic viability and market competitiveness of circular biomanufacturing.


About Insempra

Insempra GmbH is a biology-powered company enabling businesses to make superior products with nature. We combine bioscience and technology to grow matter for new and better products.

For too long, businesses have relied on chemical industrialization processes and petrochemicals, depleting our planet’s limited resources. That’s why we are committed to drive the regenerative revolution to manufacture at scale in collaboration with nature.

Led by a hand-picked team of biologists, technologists, and entrepreneurs with rebel hearts, Insempra is here to create a new school of thought and collective action. The time to restore the balance between people and the planet is now. We don’t wait for change. We do what needs to be done to grow a better future.

Learn more about Insempra at insempra.bio


About SPRIND

The Federal Agency for Disruptive Innovation, SPRIND, was created 2019 and is headquartered in Leipzig, Germany. The sole proprietor of SPRIND is the German Federal government, represented by the Ministry of Education and Research (BMBF) and the Ministry of Economic Affairs and Climate Action (BMWK). SPRIND fills a gap in the German innovation ecosystem: it discovers novel, disruptive technologies to address the greatest challenges of our time. SPRIND also ensures that the value provided by developing radically new technologies remains within Germany and Europe. SPRIND is financially supported with funding made available through the Federal budget. SPRIND is led by Rafael Laguna de la Vera and Berit Dannenberg.

Learn more about SPRIND at sprind.org


Enquiries

Insempra GmbH, [email protected]

   
Record changed: 2024-06-17

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Insempra GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture biomindz TRON LSG Mainz Translation Cancer Immunotherapy 650x300px




» top